Guest guest Posted March 18, 2011 Report Share Posted March 18, 2011 Outcomes Differ Among Hepatitis C-Related Vasculitides Doctors Lounge Among patients with hepatitis C virus-related vasculitis, those with polyarteritis nodosa have a more severe and acute clinical presentation and a higher rate of clinical remission, according to a study published online Feb. .... New drug combo for hepatitis C shows promise STLtoday.com Dr. Bruce R. Bacon, hepatitis C and liver cancer specialist at St. Louis University, examines patient Bloebaum of Troy, Ill. ( S. Cordle/PD) Researchers at St. Louis University have been testing a new drug that could increase the cure ... Minnesota nurse may have stolen painkillers, infected patients Reuters There was no evidence that blood-borne pathogens such as Hepatitis B, Hepatitis C or HIV were transmitted to the patients who suffered from bacterial infections, it said. The hospital tested all patient-controlled IV bags containing painkillers for ... See all stories on this topic » Achillion wins patent for anti-hepatitis compound Hartford Business By Seay New Haven drug developer Achillion Pharmaceuticals Inc. says its new US patent covering a key compound in its treatment for hepatitis C protects it while undergoing clinical trials to bring the drug to market but also widens the door to ... See all stories on this topic » Clinical Trial on Hepatitis C Holds Promise For Patients MedIndia by on March 17, 2011 at 9:28 AM A clinical trial of a new Hepatitis C therapy has shown that it could potentially reduce treatment time, with fewer side effects than existing drugs. The side effects of existing treatments are so severe ... See all stories on this topic » Patients of suspended doctor advised to speak with personal physicians Las Vegas Review - Journal On Tuesday, Dr. Lawrence Sands, chief health officer of the Southern Nevada Health District, said patients who underwent prostate biopsies by Kaplan could be at risk for blood-borne diseases that include HIV and hepatitis C. The prostate biopsy ... See all stories on this topic » Quote Link to comment Share on other sites More sharing options...
Guest guest Posted March 18, 2011 Report Share Posted March 18, 2011 Outcomes Differ Among Hepatitis C-Related Vasculitides Doctors Lounge Among patients with hepatitis C virus-related vasculitis, those with polyarteritis nodosa have a more severe and acute clinical presentation and a higher rate of clinical remission, according to a study published online Feb. .... New drug combo for hepatitis C shows promise STLtoday.com Dr. Bruce R. Bacon, hepatitis C and liver cancer specialist at St. Louis University, examines patient Bloebaum of Troy, Ill. ( S. Cordle/PD) Researchers at St. Louis University have been testing a new drug that could increase the cure ... Minnesota nurse may have stolen painkillers, infected patients Reuters There was no evidence that blood-borne pathogens such as Hepatitis B, Hepatitis C or HIV were transmitted to the patients who suffered from bacterial infections, it said. The hospital tested all patient-controlled IV bags containing painkillers for ... See all stories on this topic » Achillion wins patent for anti-hepatitis compound Hartford Business By Seay New Haven drug developer Achillion Pharmaceuticals Inc. says its new US patent covering a key compound in its treatment for hepatitis C protects it while undergoing clinical trials to bring the drug to market but also widens the door to ... See all stories on this topic » Clinical Trial on Hepatitis C Holds Promise For Patients MedIndia by on March 17, 2011 at 9:28 AM A clinical trial of a new Hepatitis C therapy has shown that it could potentially reduce treatment time, with fewer side effects than existing drugs. The side effects of existing treatments are so severe ... See all stories on this topic » Patients of suspended doctor advised to speak with personal physicians Las Vegas Review - Journal On Tuesday, Dr. Lawrence Sands, chief health officer of the Southern Nevada Health District, said patients who underwent prostate biopsies by Kaplan could be at risk for blood-borne diseases that include HIV and hepatitis C. The prostate biopsy ... See all stories on this topic » Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.